NexgenRX Inc. (NXG) — Cash Flow Quality Index
NexgenRX Inc. (NXG) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of CA$880.82K exceeds net income of CA$589.78K, indicating high earnings quality where cash backs reported profits. Explore NexgenRX Inc. (NXG) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NexgenRX Inc. Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for NexgenRX Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is NexgenRX Inc.'s equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for NexgenRX Inc. (2013–2024)
Year-by-year earnings quality comparison for NexgenRX Inc.. For live market cap and the full company financial profile, see market cap of NexgenRX Inc..
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.87x | CA$1.15 Million | CA$614.57K | ▲ +96.6% |
| 2021 | 0.95x | CA$3.82 Million | CA$4.02 Million | ▼ -24.1% |
| 2020 | 1.25x | CA$2.65 Million | CA$2.12 Million | ▲ +50.1% |
| 2016 | 0.84x | CA$490.96K | CA$587.80K | ▼ -34.3% |
| 2013 | 1.27x | CA$774.08K | CA$608.55K | — |